Patterns of erythropoiesis-stimulating agent use for chemotherapy-induced anemia in lung cancer: results of a retrospective Hungarian real-life clinical data analysis

By Tamáási Lilla   Müüller Veronika   Eszes Noéémi   Kardos Tamáás   Budai Marianna   Vincze Krisztina   Losonczy Gyöörgy   Szilasi Máária  

Expert Opinion on Drug Safety, Vol. 10, Iss. 4, 2011-07 ,pp. : 503-507

Informa Healthcare

Access to resources Recommend Favorite

The development of erythropoietic agents in oncology

By Glaspy John A  

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 3, 2005-08 ,pp. : 553-567

Informa Healthcare

Access to resources Recommend Favorite

Erythropoiesis-Stimulating Agents in Oncology

By Glaspy John A.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 6, 2008-07 ,pp. : 565-575

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Safety issues related to erythropoiesis-stimulating agents used to treat anemia in patients with chronic kidney disease

By Del Vecchio Lucia   Locatelli Francesco  

Expert Opinion on Drug Safety, Vol. 11, Iss. 6, 2012-11 ,pp. : 923-931

Informa Healthcare

Access to resources Recommend Favorite

Dosing and Outcomes Study of Erythropoiesis-Stimulating Therapies (DOSE): A Registry for Characterizing Anaemia Management and Outcomes in Oncology Patients

By Larholt Kay  

Clinical Drug Investigation, Vol. 28, Iss. 3, 2008-01 ,pp. : 159-167

Adis International

Access to resources Recommend Favorite